ALK/FAK/Pyk2 Inhibitor CT-707
Semantic Scholar uses AI to extract papers important to this topic.
- Journal of pharmaceutical and biomedical analysis
CT-707, a mutant-selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK), is designed to be a… (More)
Given that YAP signaling acts as a critical survival input for hypoxic cancer cells in hepatocellular carcinoma (HCC), disruption… (More)
- Molecular cancer therapeutics
Hepatocellular carcinoma is among the leading causes of cancer-related deaths worldwide, and the development of new treatment… (More)